Karbon-X Project Inc.
28.3.2024 20:02:55 CET | ACCESS Newswire | Press release
CALGARY, AB / ACCESSWIRE / March 28, 2024 / Drax Group, a pioneer in carbon removal and renewable energy, has formed a groundbreaking partnership with environmental leader Karbon-X (OTC PINK:KARX), marking a significant advancement in the deployment of Bioenergy with Carbon Capture and Storage (BECCS) technology in the United States. This collaboration underscores the escalating demand for premium carbon removal solutions.
Under this new agreement, Karbon-X will acquire Carbon Dioxide Removal (CDR) credits from Drax, corresponding to the permanent storage of 25,000 metric tons of carbon dioxide, priced at $350 per metric ton. The contract spans five years, commencing in 2030, and is tied to Drax's forthcoming BECCS initiatives within the United States.
Laurie Fitzmaurice, Drax's President of Carbon Removals, expressed enthusiasm about partnering with entities like Karbon-X that recognize the critical need for immediate investment in superior carbon removals. With the CDR market quickly evolving, there's an anticipated shortage of supply as entities worldwide near their carbon reduction milestones. "We're excited to work with organizations like Karbon-X that understand the importance of investing in high-quality carbon removals today. The CDR market, which is already maturing at a rapid pace, is expected to experience a supply crunch within the next decade as companies and countries approach their deadlines for carbon reduction targets." said Laurie Fitzmaurice, President, Carbon Removals at Drax.
This partnership is a continuation of Drax's commitment to leading in carbon removal efforts, following agreements with other significant players and the establishment of a dedicated business unit aimed at spearheading global carbon removals, targeting the extraction of at least 6 million tons of CO2 annually from the atmosphere.
BECCS technology, celebrated for its ability to produce renewable energy from sustainable biomass while capturing and permanently storing CO2, is becoming increasingly sought after for its verifiable impact, especially when compared to nature-based removal methods.
Fitzmaurice highlighted the significance of this deal with Karbon-X in propelling the implementation of BECCS in the U.S., catering to the soaring demand for decarbonization solutions. Karbon-X plans to resell the purchased credits in the voluntary carbon market, aiding companies, and individuals in achieving their emission reduction goals by choosing high-caliber projects like Drax's BECCS.
Chad Clovis, CEO of Karbon-X, praised the partnership with Drax as a monumental stride towards addressing climate change and fostering a sustainable future. "We are thrilled to be working alongside Drax in their pursuit of their carbon removals program. This partnership represents significant progress in our collective mission to combat climate change and build a more sustainable future." said Chad Clovis, CEO of Karbon-X.
As the global community increasingly turns to engineered carbon removal solutions to fulfill climate pledges, the distinct, quantifiable benefits of BECCS have positioned it as a cornerstone of high-integrity CDR efforts.
For more insights into Drax's role in supporting organizational sustainability ambitions through premier carbon removal services, please visit their website.
About Drax
Drax Group is committed to fostering a zero-carbon, cost-effective energy future. Announced in 2019, Drax's ambition to become carbon negative by 2030 leverages BECCS technology. The company's diverse team of 3,000 employees focuses on electricity generation, business electricity sales, and the production and supply of compressed wood pellets. Learn more at Drax's website, www.drax.com.
About Karbon-X
Karbon-X stands at the forefront of environmental action, offering a user-friendly platform for individuals to engage in meaningful carbon offset projects. Committed to transparency and convenience, Karbon-X supports initiatives that significantly reduce greenhouse gas emissions, empowering users to contribute to global climate change mitigation. Specializing in delivering offsets to consumers and businesses, Karbon-X is working to democratize access to carbon offsets globally. For more information, see www.karbon-x.com
Contact for Media Inquiries:
Drax Group
Alex Schott
VP, North America Communications
Email: alex.schott@drax.com
Phone: 318 - 372 - 4091
Karbon-X
Daniel Haigh
Head of Marketing
Email: dh@karbon-x.com
Phone: 587 - 577 - 3863
SOURCE: Karbon-X Project Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
RE Royalties Announces Second Tranche Investment of $800,000 in Solaris Energy's U.S. Distributed Generation Solar Portfolio9.2.2026 23:00:00 CET | Press release
All amounts in US dollars unless otherwise stated. VANCOUVER, BC / ACCESS Newswire / February 9, 2026 / RE Royalties Ltd. (TSX.V:RE)(OTCQX:RROYF)(FSE:Y2V) ("RE Royalties" or the "Company") is pleased to announce a further USD $800,000 investment toward the purchase of royalties on two portfolios of distributed generation ("DG") solar projects located throughout the United States being developed by Solaris Energy Inc. ("Solaris"). The Royalty Purchase for Portfolio 1 totals USD $4.8 million, of which USD $3 million was funded at closing, as announced on January 7, 2026. The Company expects to fund the remaining USD $1 million by Q2 2026, subject to the satisfaction of applicable conditions. The Royalty Purchase for Portfolio 2 is subject to the completion of due diligence to the satisfaction of the Company, other customary closing conditions, and is expected to occur later in the year, bringing the total portfolio level royalty investment to USD $9 million. The Royalty Rate will be adju
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities9.2.2026 06:00:00 CET | Press release
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages neurons Vesalic is pioneering a novel therapeutic to intercept and neutralise these toxins, potentially slowing or halting progression of monogenic and sporadic forms of ALS In addition, Vesalic has discovered a disease-specific alteration of the lipid composition in the membranes of exosomes circulating in the blood, and has developed a highly accurate biomarker-based technology to detect both monogenic and sporadic ALS Based on its novel biomarker discoveries, Vesalic is also applying its biomarker technology for other neurodegenerative diseases, including Alzheimer's and Parkinson's LONDON, UK / ACCESS Newswire / February 9, 2026 / Vesalic Limited, an early-stage neurodegenerative disease-focused biotech company, today emerged from stealth with the landmark discovery of a systemic process - largely
Innodata to Report Fourth Quarter and Fiscal Year 2025 Results5.2.2026 14:30:00 CET | Press release
NEW YORK, NY / ACCESS Newswire / February 5, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Fourth Quarter and Fiscal Year 2025 results after the market closes on Thursday, February 26, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 549 8228 North America (+44) 800 279 7040 United Kingdom (+1) 289 819 1520 International Participant Access Code 27117 # Replay dial-In (+1) 888 660 6264 North America (+1) 289 819 1325 International: Replay Passcode 27117 # Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be av
Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 20265.2.2026 12:00:00 CET | Press release
Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 Revenue. Revenue: Datavault AI expects at least $30 million in revenue for FY2025, compared to $2.7 million in FY2024. This represents an increase of more than 1,000% growth in our revenue over 2024. The Company continues to expand to drive substantial near- and long-term accretion to our cash flows and earnings with a revenue target for 2026 of at least $200 million. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 5, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today issued a letter from Nathaniel Bradley, its Chief Executive Officer, to its stockholders highlighting the Company's accomplishments in 2025 and its outlook for 2026. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER Dear Datavault AI Stockholders, I would like t
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
